Pediatrics
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Pediatrics Repurposing Community that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of pediatric patients.
Our repurposing research and events within the Pediatrics Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Our efforts include finding and funding clinical repurposing projects to quickly impact pediatric patients in any disease area.
Funding Opportunity RFPs for Pediatrics:
- Repurposing Research for Chicago 2026: accepting budgets of up to $125,000 for clinical repurposing trials from Chicago area research institutions in one or both of the tracks listed below. LOI SUBMISSIONS DUE MAY 8, 2026.
- Track 1 – Investigator Groups: clinical repurposing trials in any unsolved disease led by an Early Stage Investigator or an underrepresented researcher.
- Track 2 – Patient Groups: clinical repurposing trials impacting specific patient groups, such as health disparities, pediatrics, rare diseases and/or veterans issues (including mental health, PTSD and brain injuries).
- ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries 2026: accepting budgets of up to $70,000 for clinical repurposing trials in any disease led by an underresourced researcher in any LMIC, as defined by the World Bank. LOI SUBMISSIONS DUE APRIL 10, 2026.
More information on our Funding Opportunities / RFPs page.
In 2021, we held CureAccelerator Live! for Pediatric Rare Diseases. Click here to watch the full event and highlights video or read about the three funded trials from this unique philanthropic pitch event.
As we develop and grow this Pediatric Community, we thank our early collaborative partner:
Our ongoing pediatric trials:
Current Pediatric Trials
Pediatrics: Completed Trials
(in the past 5 years)
Pediatrics: Press Releases
Success Stories
Treating Children with Clostridioides Difficile Infections with FMT
Improving a Vitamin D Defect with Rifampin, a Common Antibiotic
Repurposing a Transplant Drug Saves Kids with ALPS, a Rare but Deadly Blood Disorder
Treating Development Issues in Preterm Infants and Toddlers with a Nutraceutical
